RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family

Detalhes bibliográficos
Autor(a) principal: Quedas, Elisangela P. S.
Data de Publicação: 2012
Outros Autores: Longuini, Viviane C., Sekiya, Tomoko, Coutinho, Flavia L., Toledo, Sergio P. A., Tannuri, Uenis, Toledo, Rodrigo A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/19722
Resumo: Hirschsprung disease is a congenital form of aganglionic megacolon that results from cristopathy. Hirschsprung disease usually occurs as a sporadic disease, although it may be associated with several inherited conditions, such as multiple endocrine neoplasia type 2. The rearranged during transfection (RET) proto-oncogene is the major susceptibility gene for Hirschsprung disease, and germline mutations in RET have been reported in up to 50% of the inherited forms of Hirschsprung disease and in 15-20% of sporadic cases of Hirschsprung disease. The prevalence of Hirschsprung disease in multiple endocrine neoplasia type 2 cases was recently determined to be 7.5% and the cooccurrence of Hirschsprung disease and multiple endocrine neoplasia type 2 has been reported in at least 22 families so far. It was initially thought that Hirschsprung disease could be due to disturbances in apoptosis or due to a tendency of the mutated RET receptor to be retained in the Golgi apparatus. Presently, there is strong evidence favoring the hypothesis that specific inactivating haplotypes play a key role in the fetal development of congenital megacolon/Hirschsprung disease. In the present study, we report the genetic findings in a novel family with multiple endocrine neoplasia type 2: a specific RET haplotype was documented in patients with Hirschsprung disease associated with medullary thyroid carcinoma, but it was absent in patients with only medullary thyroid carcinoma. Despite the limited number of cases, the present data favor the hypothesis that specific haplotypes not linked to RET germline mutations are the genetic causes of Hirschsprung disease.
id USP-19_9c8f6f54e006e1b5b0fd44b0edcef125
oai_identifier_str oai:revistas.usp.br:article/19722
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 familyRETMEN2HSCRHirschsprungHaplotypesHirschsprung disease is a congenital form of aganglionic megacolon that results from cristopathy. Hirschsprung disease usually occurs as a sporadic disease, although it may be associated with several inherited conditions, such as multiple endocrine neoplasia type 2. The rearranged during transfection (RET) proto-oncogene is the major susceptibility gene for Hirschsprung disease, and germline mutations in RET have been reported in up to 50% of the inherited forms of Hirschsprung disease and in 15-20% of sporadic cases of Hirschsprung disease. The prevalence of Hirschsprung disease in multiple endocrine neoplasia type 2 cases was recently determined to be 7.5% and the cooccurrence of Hirschsprung disease and multiple endocrine neoplasia type 2 has been reported in at least 22 families so far. It was initially thought that Hirschsprung disease could be due to disturbances in apoptosis or due to a tendency of the mutated RET receptor to be retained in the Golgi apparatus. Presently, there is strong evidence favoring the hypothesis that specific inactivating haplotypes play a key role in the fetal development of congenital megacolon/Hirschsprung disease. In the present study, we report the genetic findings in a novel family with multiple endocrine neoplasia type 2: a specific RET haplotype was documented in patients with Hirschsprung disease associated with medullary thyroid carcinoma, but it was absent in patients with only medullary thyroid carcinoma. Despite the limited number of cases, the present data favor the hypothesis that specific haplotypes not linked to RET germline mutations are the genetic causes of Hirschsprung disease.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2012-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1972210.6061/clinics/2012(Sup01)11Clinics; Vol. 67 No. supl.1 (2012); 57-61Clinics; v. 67 n. supl.1 (2012); 57-61Clinics; Vol. 67 Núm. supl.1 (2012); 57-611980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/19722/21786Quedas, Elisangela P. S.Longuini, Viviane C.Sekiya, TomokoCoutinho, Flavia L.Toledo, Sergio P. A.Tannuri, UenisToledo, Rodrigo A.info:eu-repo/semantics/openAccess2012-05-24T20:33:52Zoai:revistas.usp.br:article/19722Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-24T20:33:52Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family
title RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family
spellingShingle RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family
Quedas, Elisangela P. S.
RET
MEN2
HSCR
Hirschsprung
Haplotypes
title_short RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family
title_full RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family
title_fullStr RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family
title_full_unstemmed RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family
title_sort RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family
author Quedas, Elisangela P. S.
author_facet Quedas, Elisangela P. S.
Longuini, Viviane C.
Sekiya, Tomoko
Coutinho, Flavia L.
Toledo, Sergio P. A.
Tannuri, Uenis
Toledo, Rodrigo A.
author_role author
author2 Longuini, Viviane C.
Sekiya, Tomoko
Coutinho, Flavia L.
Toledo, Sergio P. A.
Tannuri, Uenis
Toledo, Rodrigo A.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Quedas, Elisangela P. S.
Longuini, Viviane C.
Sekiya, Tomoko
Coutinho, Flavia L.
Toledo, Sergio P. A.
Tannuri, Uenis
Toledo, Rodrigo A.
dc.subject.por.fl_str_mv RET
MEN2
HSCR
Hirschsprung
Haplotypes
topic RET
MEN2
HSCR
Hirschsprung
Haplotypes
description Hirschsprung disease is a congenital form of aganglionic megacolon that results from cristopathy. Hirschsprung disease usually occurs as a sporadic disease, although it may be associated with several inherited conditions, such as multiple endocrine neoplasia type 2. The rearranged during transfection (RET) proto-oncogene is the major susceptibility gene for Hirschsprung disease, and germline mutations in RET have been reported in up to 50% of the inherited forms of Hirschsprung disease and in 15-20% of sporadic cases of Hirschsprung disease. The prevalence of Hirschsprung disease in multiple endocrine neoplasia type 2 cases was recently determined to be 7.5% and the cooccurrence of Hirschsprung disease and multiple endocrine neoplasia type 2 has been reported in at least 22 families so far. It was initially thought that Hirschsprung disease could be due to disturbances in apoptosis or due to a tendency of the mutated RET receptor to be retained in the Golgi apparatus. Presently, there is strong evidence favoring the hypothesis that specific inactivating haplotypes play a key role in the fetal development of congenital megacolon/Hirschsprung disease. In the present study, we report the genetic findings in a novel family with multiple endocrine neoplasia type 2: a specific RET haplotype was documented in patients with Hirschsprung disease associated with medullary thyroid carcinoma, but it was absent in patients with only medullary thyroid carcinoma. Despite the limited number of cases, the present data favor the hypothesis that specific haplotypes not linked to RET germline mutations are the genetic causes of Hirschsprung disease.
publishDate 2012
dc.date.none.fl_str_mv 2012-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/19722
10.6061/clinics/2012(Sup01)11
url https://www.revistas.usp.br/clinics/article/view/19722
identifier_str_mv 10.6061/clinics/2012(Sup01)11
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/19722/21786
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 67 No. supl.1 (2012); 57-61
Clinics; v. 67 n. supl.1 (2012); 57-61
Clinics; Vol. 67 Núm. supl.1 (2012); 57-61
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222758293995520